Ole Andreas Halvorsen
Viking Global Investors
Viking Global Investors 13F holdings
Ole Andreas Halvorsen's Portfolio
- Portfolio value:
- $23.54B≈
- # of securities:
- 55
- Reported for:
- 30 Jun 2016 (Q2)
- Latest filing date:
- 15 Aug 2016
What stocks did Ole Andreas Halvorsen own in 2016 Q2?
What was Ole Andreas Halvorsen's 2016 Q2 portfolio?
Viking Global Investors has disclosed a total of 55 security holdings in their (2016 Q2) SEC 13F filing(s) with portfolio value of $23,540,602,000.
Viking Global Investors's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Ole Andreas Halvorsen's original 13F reports (2016 Q2) are the official SEC institutional disclosure documents covering all reported equity positions.
55 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Amazon.com Inc
|
9.97%
|
$35.78
|
+548.05%($231.88)
|
2015 Q2
|
≈ 1.25 years
|
Common Stock
|
-4.61% (-3.17M)
|
||||
|
|
Meta Platforms Inc
|
9.78%
|
$114.28
|
+420.41%($594.72)
|
2016 Q1
|
≈ 0.50 years
|
Common Stock
|
+0.06% (+11.71K)
|
||||
|
|
Broadcom Inc
|
6.75%
|
$15.54
|
+2,345.82%($380.08)
|
2015 Q2
|
≈ 1.25 years
|
Common Stock
|
+3.94% (+3.87M)
|
||||
|
|
Teva Pharma Industries Ltd ADR
|
5.92%
|
$50.23
|
-38.12%($31.08)
|
2015 Q3
|
≈ 1.00 year
|
Depositary Receipt
|
-15.88% (-5.23M)
|
||||
|
|
Alphabet Inc, CL-A
|
5.36%
|
$35.18
|
+828.38%($326.57)
|
2014 Q3
|
≈ 2.00 years
|
Common Stock
|
-12.46% (-5.11M)
|
||||
|
|
Air Products and Chemicals Inc
|
4.19%
|
$142.04
|
+106.32%($293.05)
|
2014 Q3
|
≈ 2.00 years
|
Common Stock
|
+0.52% (+36.23K)
|
||||
|
|
Coterra Energy Inc
|
3.86%
|
$25.74
|
|
2015 Q4
|
≈ 0.75 years
|
Common Stock
|
-2.96% (-1.08M)
|
||||
|
|
Biogen Inc
|
3.30%
|
$241.82
|
-16.63%($201.60)
|
2015 Q4
|
≈ 0.75 years
|
Common Stock
|
+1,290.15% (+2.98M)
|
||||
|
|
Eli Lilly and Company
|
3.14%
|
$78.75
|
+1,418.09%($1,195.50)
|
2016 Q1
|
≈ 0.50 years
|
Common Stock
|
-20.29% (-2.39M)
|
||||
|
|
ENCANA CORP
|
2.67%
|
$7.79
|
|
2015 Q4
|
≈ 0.75 years
|
Common Stock
|
|
||||
Completely sold out
21 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Elevance Health Inc
|
2015 Q2
|
≈ 1.00 year
|
|||
|
|
Transdigm Group Incorporated
|
2015 Q2
|
≈ 1.00 year
|
|||
|
|
Prudential Financial, Inc
|
2015 Q4
|
≈ 0.50 years
|
|||
|
|
ENDO HEALTH SOLUTIONS INC COM
|
2015 Q4
|
≈ 0.50 years
|
|||
|
|
Chubb Ltd
|
2016 Q1
|
≈ 0.25 years
|
|||
|
|
MetLife Inc
|
2016 Q1
|
≈ 0.25 years
|
|||
|
|
JARDEN CORP
|
2016 Q1
|
≈ 0.25 years
|
|||
|
|
Laboratory Corp of America Holdings
|
2015 Q3
|
≈ 0.75 years
|
|||
|
|
The Home Depot Inc
|
2016 Q1
|
≈ 0.25 years
|
|||
|
|
Progressive Corp
|
2016 Q1
|
≈ 0.25 years
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.